P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In

 

News Categories

 

 

Industry Trends

Report: Market for Pancreatic Cancer Therapies Expected to Double to $1.3 Billion Over Next Decade

Growth fueled by three new agents (May 7)

Physicians Expect Xtandi (Enzalutamide) to Become Treatment Leader for Metastatic Prostate Cancer

Survey finds rapid uptake since product launch (May 6)

Report: All-Oral, IFN-Free Regimen Is Major Unmet Need in HCV Patients

Sofosbuvir/ledipasvir/ribavirin combo has advantages over current therapies (May 2)

Survey: Ulcerative Colitis Drug Vedolizumab May Offer Better Remission Rates Versus Infliximab

Improved remission maintenance is greatest unmet need (Apr. 29)

Sustained Efficacy Is Among Key Unmet Needs for New SLE Treatments

Physicians wish belimumab had wider indication (Apr. 25)

Update on Deadly H7N9 Flu Strain

Current fatality rate is about 20% (Apr. 25)

Costs to Treat Heart Failure Expected to More Than Double by 2030

Aging population fuels increasing heart failure incidence, AHA says (Apr. 24)

Report: High Leukemia Treatment Costs May Be Harming Patients

Average cancer drug prices top $10,000 per month (Apr. 25)

Thought Leaders Say Eravacycline Is No. 1 for Hospital-Acquired Pneumonia

Advantages include activity against multidrug-resistant pathogens (Apr. 24)

Report: Worldwide Orphan Drug Market to Grow to $127 Billion by 2018

Predicted growth rate is double that of overall prescription drug market (Apr. 23)

Report: Uptake of Obesity Drugs Will Be Hampered by Managed Care Formulary Exclusion

Victoza (liraglutide) foreseen as new market-share leader (Apr. 16)

Expert Doubts Computer-Based Decision Support Can Control Health Care Costs

Doctors often unaware of financial implications of their decisions (Apr. 16)

ACS Report: Challenges Remain in Changing Behaviors to Reduce Cancer Risk

Group calls for coordinated efforts to close gaps (Apr. 11)

Report: Neurologists See Fixed-Dose Sumatriptan/Naproxen as ‘Gold Standard’ of Migraine Treatment

MCO pharmacy directors welcome new migraine drugs (Apr. 3)

AARP Details Improvements to Hospital Rooms to Enhance Patient Safety

Online interactive tool designed to prevent hospital mistakes (Apr. 3)

Report: Emerging Treatments Offer Improvements in Lupus Therapy

Thought leaders see only modest efficacy benefits with belimumab (Apr. 2)

Survey: Rheumatologists Concerned With Risks of Infection and Malignancy With Tofacitinib (Xeljanz)

Most patients receive second-line treatment after anti-TNF therapy (Mar. 25)

Physicians Pessimistic About the Future, Survey Finds

Many docs likely to retire early in next 3 years (Mar. 21)

Survey: Neurologists Cite Therapy’s Effect on Physical Disability as Most Important Factor Influencing Prescribing Decisions in MS

MCO pharmacy directors receptive to new treatments (Mar. 20)

Physicians Cite Diabetic Nephropathy as Renal Condition With Highest Unmet Need for Treatment

ACE inhibitors preferred over ARBs and diuretics (Mar. 14)

Survey: Formulary Placement Has Greater Importance as Clinicians Use E-Prescribing

Physicians prescribe drugs with lower patient costs and fewer restrictions (Mar. 14)

Survey: Clinicians’ Satisfaction With Electronic Health Records Has Declined Since 2010

Almost 40% wouldn’t recommend their EHR to a colleague (Mar. 5)

Five Things Physicians and Patients Should Question

Specialty societies issue lists of unnecessary tests and procedures (Feb. 21)

Report: About One-Third of Chemotherapies Used Off Label

Bevacizumab biggest contributor to off-label costs (Feb. 19)

Report: Rise in Drug Costs to Hospitals, Clinics Slowing in 2013

Researchers find rise less than in previous years; cancer drugs the exception (Feb. 15)

Survey: Rural Seniors Face Challenges From Medicare Part D Preferred Pharmacy Drug Plans

‘Preferred pharmacies’ may be far from seniors’ homes (Feb. 7)

Study Predicts Alzheimer’s Disease Will Triple by 2050

More than 7 million patients will be 85 years old and older (Feb. 6)

Report: Treatment Landscape for Thyroid Cancer Will Change Dramatically Through 2021

Several new drugs poised to enter the marketplace (Feb. 4)

Study Finds Nearly Half of Children Under 2 Years of Age Receive Vaccinations Late

Under-vaccinated children more likely to be admitted to hospitals (Jan. 21)

Report: Simple Policy Change Could Solve U.S. Physician Shortages in 25 States

Authors call for equal licensure requirements for foreign-educated and U.S.-educated docs (Jan. 22)

CDC Briefing: Flu Widespread in U.S., But Starting to Ease

Millions of vaccine units remain available (Jan. 18)

Report: U.S. Cancer Mortality Down 20% From 1991 Peak

American Cancer Society issues annual review (Jan. 17)

Mayo Clinic Report: Skin Problems, Joint Disorders Head List of Reasons People Visit Doctors

Skin disorders affect almost half of study population (Jan. 16)

Report: States Need to Do More to Reduce Smoking

American Lung Association issues scathing assessment (Jan. 16)

Report: Generic HIV Treatment Strategy Could Save Nearly $1 Billion Annually

But treatment may be less effective (Jan. 15)